Yaz Associated With Increased Risk of Blood Clots
Filled under Recovering Damages, Yaz/Yasmin on April 29, 2011 - no comments .A recent study published in the British Medical Journal found the risk of non-fatal blood clots (venous thromboembolism) among users of oral contraceptives containing drospirenone seems to be around twice that of users of oral contraceptives containing levonorgestrel. Yaz and Yasmin contain drospirenone. Yaz is one of the best selling birth control pills in the United States. Bayer the manufacturer of Yaz and Yasmin responded by criticizing the study. James Esparza has substantial experience in
Read more...


